Treatment of type-A aortic dissection using endoprosthesis occurring after coronary artery bypass surgery

Gustavo Pires de Morais1, Alberto Rodrigues, Vasco Gama

  • 1University of Porto and Cardiovascular Interventional Unit, Department of Cardiology, Centro Hospitalar de Gaia, Portugal. gpmorais@gmail.com

Insights

Type-A aortic dissection after coronary artery bypass surgery (CABG) is rare and deadly. Endoprosthetic repair, using an abdominal aorta prosthesis, offers a viable treatment option, improving patient outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Endoprothesis
  • Aortic Dissection

Background:

  • Type-A aortic dissection is a rare, life-threatening complication post-coronary artery bypass surgery (CABG).
  • Traditional surgical repair of Type-A aortic dissection following CABG has limited success and poor patient outcomes.
  • Endovascular repair presents a potential alternative for managing this complex condition.

Observation:

  • A case report details the transluminal endoprosthetic correction of acute Type-A aortic dissection in a 66-year-old male, one year after CABG.
  • The patient had a history of ischemic heart disease and severely compromised left ventricular function.
  • A prosthesis intended for abdominal aortic repair was successfully adapted and implanted.

Findings:

  • The endoprosthetic repair was technically successful, with the patient remaining stable in New York Heart Association class II at nearly 3 years post-implantation.
  • This represents, to the authors' knowledge, the first reported case of endoprosthetic repair for Type-A aortic dissection in a patient with prior CABG using saphenous grafts.

Implications:

  • Endoprosthetic repair may be a feasible and effective treatment for Type-A aortic dissection in patients with prior CABG.
  • This approach could offer a less invasive option compared to open surgery, potentially improving outcomes in this high-risk population.
  • Further research and case studies are warranted to establish the long-term efficacy and safety of endovascular repair for post-CABG aortic dissections.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...